Last 12 months
Inside the activity.
0 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 24, 2022 Filed Feb 28, 2022 17:15 UTC |
QUAY STEVEN CDirector · President & CEO
|
GrantStock Option (right to buy) · Derivative | 1,900,000 | $0.00 Strike: $1.25 | $0.00 |
DisclosureSEC source: 0001437749-22-004667 · rdgdoc.xml · derivative · entry 1 QUAY STEVEN C · CIK 0001008227 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,900,000 Underlying: Common Stock · 1,900,000 shares Expires 2032-02-24 F1 · derivative.exercise_date: The options will vest on a quarterly basis over two (2) years. Read SEC document |
| February 24, 2022 Filed Feb 28, 2022 22:15 UTC |
Guse KyleCFO, Gen Counsel and Secretary
|
GrantStock Option (right to buy) · Derivative | 746,667 | $0.00 Strike: $1.25 | $0.00 |
DisclosureSEC source: 0001437749-22-004668 · rdgdoc.xml · derivative · entry 1 Guse Kyle · CIK 0001566618 · CFO, Gen Counsel and Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 746,667 Underlying: Common Stock · 746,667 shares Expires 2032-02-24 F1 · derivative.exercise_date: The options will vest on a quarterly basis over two (2) years. Read SEC document |
| July 02, 2021 Filed Jul 7, 2021 20:29 UTC |
WEAVER GREGORY LDirector
|
Exercise / conversionStock Option (right to buy) · Derivative | 70,000 | $0.00 Strike: $1.70 | $0.00 |
DisclosureSEC source: 0001437749-21-016573 · rdgdoc.xml · derivative · entry 10 WEAVER GREGORY L · CIK 0001251779 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 70,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: These options were granted on May 15, 2020, vested on a quarterly basis over 12 months and expire 10 years from the grant date. F6 · derivative.expiration_date: These options were granted on May 15, 2020, vested on a quarterly basis over 12 months and expire 10 years from the grant date. Read SEC document |
| July 02, 2021 Filed Jul 7, 2021 20:29 UTC |
WEAVER GREGORY LDirector
|
Exercise / conversionStock Option (right to buy) · Derivative | 45,000 | $0.00 Strike: $2.52 | $0.00 |
DisclosureSEC source: 0001437749-21-016573 · rdgdoc.xml · derivative · entry 9 WEAVER GREGORY L · CIK 0001251779 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 45,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: These options were granted on May 17, 2019, vested on a quarterly basis over 12 months and expire 10 years from the grant date. F5 · derivative.expiration_date: These options were granted on May 17, 2019, vested on a quarterly basis over 12 months and expire 10 years from the grant date. Read SEC document |
| July 02, 2021 Filed Jul 7, 2021 20:29 UTC |
WEAVER GREGORY LDirector
|
Exercise / conversionStock Option (right to buy) · Derivative | 45,000 | $0.00 Strike: $2.38 | $0.00 |
DisclosureSEC source: 0001437749-21-016573 · rdgdoc.xml · derivative · entry 8 WEAVER GREGORY L · CIK 0001251779 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 45,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: These options were granted on June 27, 2018, vested on a quarterly basis over 12 months and expire 10 years from the grant date. F4 · derivative.expiration_date: These options were granted on June 27, 2018, vested on a quarterly basis over 12 months and expire 10 years from the grant date. Read SEC document |
| July 02, 2021 Filed Jul 7, 2021 20:29 UTC |
WEAVER GREGORY LDirector
|
Exercise / conversionStock Option (right to buy) · Derivative | 4,581 | $0.00 Strike: $5.64 | $0.00 |
DisclosureSEC source: 0001437749-21-016573 · rdgdoc.xml · derivative · entry 7 WEAVER GREGORY L · CIK 0001251779 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,581 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: These options were granted on May 24, 2017, vested on a quarterly basis over 12 months and expire 10 years from the grant date. F3 · derivative.expiration_date: These options were granted on May 24, 2017, vested on a quarterly basis over 12 months and expire 10 years from the grant date. Read SEC document |
| July 02, 2021 Filed Jul 7, 2021 20:29 UTC |
WEAVER GREGORY LDirector
|
SaleCommon Stock | 107,497 | $5.58 | $599,833.26 |
DisclosureSEC source: 0001437749-21-016573 · rdgdoc.xml · nonDerivative · entry 6 WEAVER GREGORY L · CIK 0001251779 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F2 · price: Reflects the weighted average sale price. The range of prices for such transaction is $5.51 to $5.65. Open market sale transactions were made on the same day at different prices through a trade order executed by a broker-dealer. The reporting person has reported on a single line all such transactions that occurred within a one dollar price range. The reporting person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer or a shareholder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| July 02, 2021 Filed Jul 7, 2021 20:29 UTC |
WEAVER GREGORY LDirector
|
Tax withholdingCommon Stock | 57,084 | $6.40 | $365,337.60 |
DisclosureSEC source: 0001437749-21-016573 · rdgdoc.xml · nonDerivative · entry 5 WEAVER GREGORY L · CIK 0001251779 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 107,497 F1 · price: Reflects the Nasdaq closing price of the Issuer's common stock on July 01, 2021. Read SEC document |
| July 02, 2021 Filed Jul 7, 2021 20:29 UTC |
WEAVER GREGORY LDirector
|
Exercise / conversionCommon Stock | 70,000 | $1.70 | $119,000.00 |
DisclosureSEC source: 0001437749-21-016573 · rdgdoc.xml · nonDerivative · entry 4 WEAVER GREGORY L · CIK 0001251779 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 164,581 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 02, 2021 Filed Jul 7, 2021 20:29 UTC |
WEAVER GREGORY LDirector
|
Exercise / conversionCommon Stock | 45,000 | $2.52 | $113,400.00 |
DisclosureSEC source: 0001437749-21-016573 · rdgdoc.xml · nonDerivative · entry 3 WEAVER GREGORY L · CIK 0001251779 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 94,581 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 02, 2021 Filed Jul 7, 2021 20:29 UTC |
WEAVER GREGORY LDirector
|
Exercise / conversionCommon Stock | 45,000 | $2.38 | $107,100.00 |
DisclosureSEC source: 0001437749-21-016573 · rdgdoc.xml · nonDerivative · entry 2 WEAVER GREGORY L · CIK 0001251779 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,581 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 02, 2021 Filed Jul 7, 2021 20:29 UTC |
WEAVER GREGORY LDirector
|
Exercise / conversionCommon Stock | 4,581 | $5.64 | $25,836.84 |
DisclosureSEC source: 0001437749-21-016573 · rdgdoc.xml · nonDerivative · entry 1 WEAVER GREGORY L · CIK 0001251779 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,581 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 14, 2021 Filed May 18, 2021 16:18 UTC |
QUAY STEVEN CDirector · President & CEO
|
GrantStock Option (right to buy) · Derivative | 1,900,000 | $0.00 Strike: $2.90 | $0.00 |
DisclosureSEC source: 0001437749-21-012674 · rdgdoc.xml · derivative · entry 1 QUAY STEVEN C · CIK 0001008227 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,900,000 Underlying: Common Stock · 1,900,000 shares Expires 2031-05-14 F1 · derivative.exercise_date: The options will vest on a quarterly basis over the next 24 months. Option grant was issued at 4:30 p.m. (ET) on May 14, 2021 with an exercise price of $2.90, representing the most recently reported closing stock price at the time of grant. Read SEC document |
| May 14, 2021 Filed May 18, 2021 16:18 UTC |
QUAY STEVEN CDirector · President & CEO
|
GrantStock Option (right to buy) · Derivative | 1,900,000 | $0.00 Strike: $2.90 | $0.00 |
DisclosureSEC source: 0001437749-21-012676 · rdgdoc.xml · derivative · entry 1 QUAY STEVEN C · CIK 0001008227 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,900,000 Underlying: Common Stock · 1,900,000 shares Expires 2031-05-14 F1 · derivative.exercise_date: The options will vest on a quarterly basis over the next 24 months. Option grant was issued at 4:30 p.m. (ET) on May 14, 2021 with an exercise price of $2.90, representing the most recently reported closing stock price at the time of grant. Read SEC document |
| May 14, 2021 Filed May 18, 2021 20:18 UTC |
Galli Stephen JDirector
|
GrantStock Option (right to buy) · Derivative | 50,000 | $0.00 Strike: $2.90 | $0.00 |
DisclosureSEC source: 0001437749-21-012678 · rdgdoc.xml · derivative · entry 1 Galli Stephen J · CIK 0001551951 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2031-05-14 F1 · derivative.exercise_date: The options shall vest on a quarterly basis over the next 12 months. Option grant was issued at 4:30 p.m. (ET) on May 14, 2021 with an exercise price of $2.90, representing the most recently reported closing stock price at the time of grant. Read SEC document |
| May 14, 2021 Filed May 18, 2021 20:18 UTC |
Guse KyleCFO, Gen Counsel and Secretary
|
GrantStock Option (right to buy) · Derivative | 850,000 | $0.00 Strike: $2.90 | $0.00 |
DisclosureSEC source: 0001437749-21-012675 · rdgdoc.xml · derivative · entry 1 Guse Kyle · CIK 0001566618 · CFO, Gen Counsel and Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 850,000 Underlying: Common Stock · 850,000 shares Expires 2031-05-14 F1 · derivative.exercise_date: The options will vest on a quarterly basis over the next 24 months. Option grant was issued at 4:30 p.m. (ET) on May 14, 2021 with an exercise price of $2.90, representing the most recently reported closing stock price at the time of grant. Read SEC document |
| May 14, 2021 Filed May 18, 2021 20:18 UTC |
Chen Shu-ChihDirector
|
GrantStock Option (right to buy) · Derivative | 50,000 | $0.00 Strike: $2.90 | $0.00 |
DisclosureSEC source: 0001437749-21-012677 · rdgdoc.xml · derivative · entry 1 Chen Shu-Chih · CIK 0001552127 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2031-05-14 F1 · derivative.exercise_date: The options shall vest on a quarterly basis over the next 12 months. Option grant was issued at 4:30 p.m. (ET) on May 14, 2021 with an exercise price of $2.90, representing the most recently reported closing stock price at the time of grant. Read SEC document |
| May 14, 2021 Filed May 18, 2021 20:18 UTC |
Remmel H. LawrenceDirector
|
GrantStock Option (right to buy) · Derivative | 50,000 | $0.00 Strike: $2.90 | $0.00 |
DisclosureSEC source: 0001437749-21-012673 · rdgdoc.xml · derivative · entry 1 Remmel H. Lawrence · CIK 0001551817 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2031-05-14 F1 · derivative.exercise_date: The options shall vest on a quarterly basis over the next 12 months. Option grant was issued at 4:30 p.m. (ET) on May 14, 2021 with an exercise price of $2.90, representing the most recently reported closing stock price at the time of grant. Read SEC document |
| May 14, 2021 Filed May 18, 2021 20:16 UTC |
WEAVER GREGORY LDirector
|
GrantStock Option (right to buy) · Derivative | 50,000 | $0.00 Strike: $2.90 | $0.00 |
DisclosureSEC source: 0001437749-21-012671 · rdgdoc.xml · derivative · entry 1 WEAVER GREGORY L · CIK 0001251779 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2031-05-14 F1 · derivative.exercise_date: The options shall vest on a quarterly basis over the next 12 months. Option grant was issued at 4:30 p.m. (ET) on May 14, 2021 with an exercise price of $2.90, representing the most recently reported closing stock price at the time of grant. Read SEC document |
| May 14, 2021 Filed May 18, 2021 20:16 UTC |
Steinhart Richard IDirector
|
GrantStock Option (right to buy) · Derivative | 50,000 | $0.00 Strike: $2.90 | $0.00 |
DisclosureSEC source: 0001437749-21-012672 · rdgdoc.xml · derivative · entry 1 Steinhart Richard I · CIK 0001293789 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2031-05-14 F1 · derivative.exercise_date: The options shall vest on a quarterly basis over the next 12 months. Option grant was issued at 4:30 p.m. (ET) on May 14, 2020 with an exercise price of $2.90, representing the most recently reported closing stock price at the time of grant. Read SEC document |
| May 15, 2020 Filed May 19, 2020 18:06 UTC |
Remmel H. LawrenceDirector
|
GrantStock Option (right to buy) · Derivative | 45,000 | $0.00 Strike: $1.70 | $0.00 |
DisclosureSEC source: 0001437749-20-011265 · rdgdoc.xml · derivative · entry 1 Remmel H. Lawrence · CIK 0001551817 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,000 Underlying: Common Stock · 45,000 shares Expires 2030-05-15 F1 · derivative.exercise_date: The options shall vest on a quarterly basis over the next 12 months. Option grant was issued at 4:30 p.m. (ET) on May 15, 2020 with an exercise price of $1.70, representing the most recently reported closing stock price at the time of grant. Read SEC document |
| May 15, 2020 Filed May 19, 2020 18:06 UTC |
WEAVER GREGORY LDirector
|
GrantStock Option (right to buy) · Derivative | 70,000 | $0.00 Strike: $1.70 | $0.00 |
DisclosureSEC source: 0001437749-20-011264 · rdgdoc.xml · derivative · entry 1 WEAVER GREGORY L · CIK 0001251779 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,000 Underlying: Common Stock · 70,000 shares Expires 2030-05-15 F1 · derivative.exercise_date: The options shall vest on a quarterly basis over the next 12 months. Option grant was issued at 4:30 p.m. (ET) on May 15, 2020 with an exercise price of $1.70, representing the most recently reported closing stock price at the time of grant. Read SEC document |
| May 15, 2020 Filed May 19, 2020 18:06 UTC |
Steinhart Richard IDirector
|
GrantStock Option (right to buy) · Derivative | 45,000 | $0.00 Strike: $1.70 | $0.00 |
DisclosureSEC source: 0001437749-20-011263 · rdgdoc.xml · derivative · entry 1 Steinhart Richard I · CIK 0001293789 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,000 Underlying: Common Stock · 45,000 shares Expires 2030-05-15 F1 · derivative.exercise_date: The options shall vest on a quarterly basis over the next 12 months. Option grant was issued at 4:30 p.m. (ET) on May 15, 2020 with an exercise price of $1.70, representing the most recently reported closing stock price at the time of grant. Read SEC document |
| May 15, 2020 Filed May 19, 2020 18:05 UTC |
Chen Shu-ChihDirector
|
GrantStock Option (right to buy) · Derivative | 45,000 | $0.00 Strike: $1.70 | $0.00 |
DisclosureSEC source: 0001437749-20-011262 · rdgdoc.xml · derivative · entry 1 Chen Shu-Chih · CIK 0001552127 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,000 Underlying: Common Stock · 45,000 shares Expires 2030-05-15 F1 · derivative.exercise_date: The options shall vest on a quarterly basis over the next 12 months. Option grant was issued at 4:30 p.m. (ET) on May 15, 2020 with an exercise price of $1.70, representing the most recently reported closing stock price at the time of grant. Read SEC document |
| May 15, 2020 Filed May 19, 2020 18:05 UTC |
Galli Stephen JDirector
|
GrantStock Option (right to buy) · Derivative | 45,000 | $0.00 Strike: $1.70 | $0.00 |
DisclosureSEC source: 0001437749-20-011261 · rdgdoc.xml · derivative · entry 1 Galli Stephen J · CIK 0001551951 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,000 Underlying: Common Stock · 45,000 shares Expires 2030-05-15 F1 · derivative.exercise_date: The options shall vest on a quarterly basis over the next 12 months. Option grant was issued at 4:30 p.m. (ET) on May 15, 2020 with an exercise price of $1.70, representing the most recently reported closing stock price at the time of grant. Read SEC document |
| April 09, 2020 Filed Apr 13, 2020 18:20 UTC |
QUAY STEVEN CDirector · President & CEO
|
GrantStock Option (Right to Buy) · Derivative | 1,305,000 | $0.00 Strike: $1.48 | $0.00 |
DisclosureSEC source: 0001437749-20-007628 · rdgdoc.xml · derivative · entry 2 QUAY STEVEN C · CIK 0001008227 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,305,000 Underlying: Common Shares · 1,305,000 shares Expires 2030-04-09 F2 · derivative.exercise_date: The options will vest quarterly in equal amounts over two years from the grant date (April 9, 2020), subject to continued employment with the Company through the applicable vesting dates. However, 50% of all then-unvested options will vest immediately upon the achievement of certain milestones. The stock options are also subject to stockholder approval of the 2020 Stock Incentive Plan of the Company, which approval must occur within one year from the grant date. Read SEC document |
| April 09, 2020 Filed Apr 13, 2020 18:20 UTC |
QUAY STEVEN CDirector · President & CEO
|
GrantStock Option (Right to Buy) · Derivative | 195,000 | $0.00 Strike: $1.48 | $0.00 |
DisclosureSEC source: 0001437749-20-007628 · rdgdoc.xml · derivative · entry 1 QUAY STEVEN C · CIK 0001008227 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 195,000 Underlying: Common Shares · 195,000 shares Expires 2030-04-09 F1 · derivative.exercise_date: The options will vest quarterly in equal amounts over two years from the grant date (April 9, 2020), subject to continued employment with the Company through the applicable vesting dates. Read SEC document |
| April 09, 2020 Filed Apr 13, 2020 22:21 UTC |
Guse KyleCFO, Gen Counsel and Secretary
|
GrantStock Option (Right to Buy) · Derivative | 395,000 | $0.00 Strike: $1.48 | $0.00 |
DisclosureSEC source: 0001437749-20-007630 · rdgdoc.xml · derivative · entry 2 Guse Kyle · CIK 0001566618 · CFO, Gen Counsel and Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 395,000 Underlying: Common Shares · 395,000 shares Expires 2030-04-09 F2 · derivative.exercise_date: The options will vest quarterly in equal amounts over two years from the grant date (April 9, 2020), subject to continued employment with the Company through the applicable vesting dates. However, 50% of all then-unvested options will vest immediately upon the achievement of certain milestones. The stock options are also subject to stockholder approval of the 2020 Stock Incentive Plan of the Company, which approval must occur within one year from the grant date. Read SEC document |
| April 09, 2020 Filed Apr 13, 2020 22:21 UTC |
Guse KyleCFO, Gen Counsel and Secretary
|
GrantStock Option (Right to Buy) · Derivative | 195,000 | $0.00 Strike: $1.48 | $0.00 |
DisclosureSEC source: 0001437749-20-007630 · rdgdoc.xml · derivative · entry 1 Guse Kyle · CIK 0001566618 · CFO, Gen Counsel and Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 195,000 Underlying: Common Shares · 195,000 shares Expires 2030-04-09 F1 · derivative.exercise_date: The options will vest quarterly in equal amounts over two years from the grant date (April 9, 2020), subject to continued employment with the Company through the applicable vesting dates. Read SEC document |
| May 17, 2019 Filed May 22, 2019 00:07 UTC |
WEAVER GREGORY LDirector
|
GrantStock Option (right to buy) · Derivative | 45,000 | $0.00 Strike: $2.52 | $0.00 |
DisclosureSEC source: 0001437749-19-010648 · rdgdoc.xml · derivative · entry 1 WEAVER GREGORY L · CIK 0001251779 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,000 Underlying: Common Stock · 45,000 shares Expires 2029-05-17 F1 · derivative.exercise_date: The options shall vest on a quarterly basis over the next 12 months. Option grant was issued at 9:00 a.m. (ET) on May 17, 2019 with an exercise price of $2.52, representing the most recently reported closing stock price at the time of grant. Read SEC document |
| May 17, 2019 Filed May 22, 2019 00:07 UTC |
Steinhart Richard IDirector
|
GrantStock Option (right to buy) · Derivative | 45,000 | $0.00 Strike: $2.52 | $0.00 |
DisclosureSEC source: 0001437749-19-010647 · rdgdoc.xml · derivative · entry 1 Steinhart Richard I · CIK 0001293789 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,000 Underlying: Common Stock · 45,000 shares Expires 2029-05-17 F1 · derivative.exercise_date: The options shall vest on a quarterly basis over the next 12 months. Option grant was issued at 9:00 a.m. (ET) on May 17, 2019 with an exercise price of $2.52, representing the most recently reported closing stock price at the time of grant. Read SEC document |
| May 17, 2019 Filed May 22, 2019 00:07 UTC |
Galli Stephen JDirector
|
GrantStock Option (right to buy) · Derivative | 45,000 | $0.00 Strike: $2.52 | $0.00 |
DisclosureSEC source: 0001437749-19-010646 · rdgdoc.xml · derivative · entry 1 Galli Stephen J · CIK 0001551951 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,000 Underlying: Common Stock · 45,000 shares Expires 2019-05-17 F1 · derivative.exercise_date: The options shall vest on a quarterly basis over the next 12 months. Option grant was issued at 9:00 a.m. (ET) on May 17, 2019 with an exercise price of $2.52, representing the most recently reported closing stock price at the time of grant. Read SEC document |
| May 17, 2019 Filed May 22, 2019 00:07 UTC |
Remmel H. LawrenceDirector
|
GrantStock Option (right to buy) · Derivative | 45,000 | $0.00 Strike: $2.52 | $0.00 |
DisclosureSEC source: 0001437749-19-010645 · rdgdoc.xml · derivative · entry 1 Remmel H. Lawrence · CIK 0001551817 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,000 Underlying: Common Stock · 45,000 shares Expires 2029-05-17 F1 · derivative.exercise_date: The options shall vest on a quarterly basis over the next 12 months. Option grant was issued at 9:00 a.m. (ET) on May 17, 2019 with an exercise price of $2.52, representing the most recently reported closing stock price at the time of grant. Read SEC document |
| May 17, 2019 Filed May 22, 2019 00:07 UTC |
Chen Shu-ChihDirector
|
GrantStock Option (right to buy) · Derivative | 45,000 | $0.00 Strike: $2.52 | $0.00 |
DisclosureSEC source: 0001437749-19-010644 · rdgdoc.xml · derivative · entry 1 Chen Shu-Chih · CIK 0001552127 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,000 Underlying: Common Stock · 45,000 shares Expires 2029-05-17 F1 · derivative.exercise_date: The options shall vest on a quarterly basis over the next 12 months. Option grant was issued at 9:00 a.m. (ET) on May 17, 2019 with an exercise price of $2.52, representing the most recently reported closing stock price at the time of grant. Read SEC document |
| January 13, 2019 Filed Jan 15, 2019 16:10 UTC |
QUAY STEVEN CDirector · President & CEO
|
GrantStock Option (Right to Buy) · Derivative | 2,300,000 | $0.00 Strike: $1.36 | $0.00 |
DisclosureSEC source: 0001615774-19-000645 · s115379_form4.xml · derivative · entry 2 QUAY STEVEN C · CIK 0001008227 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,300,000 Underlying: Common Shares · 2,300,000 shares Expires 2029-01-13 F1 · kind: The June 27, 2018 options are being rescinded and a new option is being granted in order to: (i) impose a shareholder-approval requirement for the new option grant, and (ii) remove the cash settlement feature and associated liability from the June 27, 2018 grant. F3 · derivative.exercise_date: Subject to stockholder approval of the option grant, the option will vest and be exercisable with respect to: (i) 25% of the underlying shares as of the grant date (January 13, 2019), (ii) 50% of the underlying shares over a two-year period (vesting ratably quarterly) from June 27, 2018, and (iii) 25% of the underlying shares upon achievement of certain milestones. If the option grant is not approved by stockholders, then the option will not be exercisable. Read SEC document |
| January 13, 2019 Filed Jan 15, 2019 16:10 UTC |
QUAY STEVEN CDirector · President & CEO
|
Disposition to issuerStock Option (Right to Buy) · Derivative | 2,300,000 | $0.00 Strike: $2.38 | $0.00 |
DisclosureSEC source: 0001615774-19-000645 · s115379_form4.xml · derivative · entry 1 QUAY STEVEN C · CIK 0001008227 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Shares · 2,300,000 shares Expires 2028-06-27 F1 · kind: The June 27, 2018 options are being rescinded and a new option is being granted in order to: (i) impose a shareholder-approval requirement for the new option grant, and (ii) remove the cash settlement feature and associated liability from the June 27, 2018 grant. F2 · derivative.exercise_date: Twenty-five percent of the options were vested as of the grant date (June 27, 2018), 50% of the options will vest quarterly over two years from the grant date, and the remaining 25% will vest upon achievement of certain milestones. Read SEC document |
| January 13, 2019 Filed Jan 15, 2019 21:10 UTC |
Guse KyleCFO, Gen Counsel and Secretary
|
GrantStock Option (Right to Buy) · Derivative | 800,000 | $0.00 Strike: $1.36 | $0.00 |
DisclosureSEC source: 0001615774-19-000644 · s115378_form4.xml · derivative · entry 2 Guse Kyle · CIK 0001566618 · CFO, Gen Counsel and Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 800,000 Underlying: Common Shares · 800,000 shares Expires 2029-01-13 F1 · kind: The June 27, 2018 options are being rescinded and a new option is being granted in order to: (i) impose a shareholder-approval requirement for the new option grant, and (ii) remove the cash settlement feature and associated liability from the June 27, 2018 grant. F3 · derivative.exercise_date: Subject to stockholder approval of the option grant, the option will vest and be exercisable with respect to: (i) 25% of the underlying shares as of the grant date (January 13, 2019), (ii) 50% of the underlying shares over a two-year period (vesting ratably quarterly) from June 27, 2018, and (iii) 25% of the underlying shares upon achievement of certain milestones. If the option grant is not approved by stockholders, then the option will not be exercisable. Read SEC document |
| January 13, 2019 Filed Jan 15, 2019 21:10 UTC |
Guse KyleCFO, Gen Counsel and Secretary
|
Disposition to issuerStock Option (Right to Buy) · Derivative | 700,000 | $0.00 Strike: $2.38 | $0.00 |
DisclosureSEC source: 0001615774-19-000644 · s115378_form4.xml · derivative · entry 1 Guse Kyle · CIK 0001566618 · CFO, Gen Counsel and Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Shares · 700,000 shares Expires 2028-06-27 F1 · kind: The June 27, 2018 options are being rescinded and a new option is being granted in order to: (i) impose a shareholder-approval requirement for the new option grant, and (ii) remove the cash settlement feature and associated liability from the June 27, 2018 grant. F2 · derivative.exercise_date: Twenty-five percent of the options were vested as of the grant date (June 27, 2018), 50% of the options will vest quarterly over two years from the grant date, and the remaining 25% will vest upon achievement of certain milestones. Read SEC document |
| June 27, 2018 Filed Jun 29, 2018 16:03 UTC |
QUAY STEVEN CDirector · President & CEO
|
GrantStock Option (right to buy) · Derivative | 2,300,000 | $0.00 Strike: $2.38 | $0.00 |
DisclosureSEC source: 0001615774-18-005997 · s111131_form4.xml · derivative · entry 1 QUAY STEVEN C · CIK 0001008227 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,300,000 Underlying: Common Stock · 2,300,000 shares Expires 2028-06-27 F1 · derivative.exercise_date: Twenty-five percent of the options have vested as of the grant date, 50% of the options will vest quarterly over two years, and the remaining 25% will vest upon achievement of certain milestones. Read SEC document |
| June 27, 2018 Filed Jun 29, 2018 20:04 UTC |
Guse KyleCFO, Gen Counsel and Secretary
|
GrantStock Option (right to buy) · Derivative | 700,000 | $0.00 Strike: $2.38 | $0.00 |
DisclosureSEC source: 0001615774-18-006001 · s111134_form4.xml · derivative · entry 1 Guse Kyle · CIK 0001566618 · CFO, Gen Counsel and Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 700,000 Underlying: Common Stock · 700,000 shares Expires 2028-06-27 F1 · derivative.exercise_date: Twenty-five percent of the options have vested as of the grant date, 50% of the options will vest quarterly over two years, and the remaining 25% will vest upon achievement of certain milestones. Read SEC document |
| June 27, 2018 Filed Jun 29, 2018 20:04 UTC |
Remmel H. LawrenceDirector
|
GrantStock Option (right to buy) · Derivative | 45,000 | $0.00 Strike: $2.38 | $0.00 |
DisclosureSEC source: 0001615774-18-006000 · s111133_form4.xml · derivative · entry 1 Remmel H. Lawrence · CIK 0001551817 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,000 Underlying: Common Stock · 45,000 shares Expires 2028-06-27 F1 · derivative.exercise_date: The options shall vest on a quarterly basis over the next 12 months. Read SEC document |
| June 27, 2018 Filed Jun 29, 2018 20:03 UTC |
Steinhart Richard IDirector
|
GrantStock Option (right to buy) · Derivative | 45,000 | $0.00 Strike: $2.38 | $0.00 |
DisclosureSEC source: 0001615774-18-005998 · s111132_form4.xml · derivative · entry 1 Steinhart Richard I · CIK 0001293789 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,000 Underlying: Common Stock · 45,000 shares Expires 2028-06-27 F1 · derivative.exercise_date: The options shall vest on a quarterly basis over the next 12 months. Read SEC document |
| June 27, 2018 Filed Jun 29, 2018 20:02 UTC |
Chen Shu-ChihDirector
|
GrantStock Option (right to buy) · Derivative | 45,000 | $0.00 Strike: $2.38 | $0.00 |
DisclosureSEC source: 0001615774-18-005996 · s111130_form4.xml · derivative · entry 1 Chen Shu-Chih · CIK 0001552127 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,000 Underlying: Common Stock · 45,000 shares Expires 2028-06-27 F1 · derivative.exercise_date: The options shall vest on a quarterly basis over the next 12 months. Read SEC document |
| June 27, 2018 Filed Jun 29, 2018 20:02 UTC |
Galli Stephen JDirector
|
GrantStock Option (right to buy) · Derivative | 45,000 | $0.00 Strike: $2.38 | $0.00 |
DisclosureSEC source: 0001615774-18-005995 · s111129_form4.xml · derivative · entry 1 Galli Stephen J · CIK 0001551951 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,000 Underlying: Common Stock · 45,000 shares Expires 2028-06-27 F1 · derivative.exercise_date: The options shall vest on a quarterly basis over the next 12 months. Read SEC document |
| June 27, 2018 Filed Jun 29, 2018 20:02 UTC |
WEAVER GREGORY LDirector
|
GrantStock Option (right to buy) · Derivative | 45,000 | $0.00 Strike: $2.38 | $0.00 |
DisclosureSEC source: 0001615774-18-005994 · s111128_form4.xml · derivative · entry 1 WEAVER GREGORY L · CIK 0001251779 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,000 Underlying: Common Stock · 45,000 shares Expires 2028-06-27 F1 · derivative.exercise_date: The options shall vest on a quarterly basis over the next 12 months. Read SEC document |
| May 30, 2018 Filed May 31, 2018 15:26 UTC |
QUAY STEVEN CDirector · President & CEO
|
PurchaseWarrants · Derivative | 2,272 | $1,000.00 Strike: $4.05 | $2,272,000.00 |
DisclosureSEC source: 0001615774-18-004657 · s110546_form4.xml · derivative · entry 2 QUAY STEVEN C · CIK 0001008227 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 2,272 Underlying: Common Stock · 2,272 shares Expires 2022-05-30 F4 · price: Shares of Series B Convertible Preferred Stock and Warrants were issued as part of a unit, with each unit consisting of one share of Series B Convertible Preferred Stock and 284 Warrants. F5 · ownership.nature: Securities are owned by Ensisheim Partners, LLC ("Ensisheim"). Shu-Chih Chen, Ph.D. and Steven C. Quay, M.D., Ph.D., share voting and investment power over the securities held by Ensisheim. Ensisheim is solely owned and controlled by Drs. Chen and Quay, and, as a result, Drs. Chen and Quay are deemed to be beneficial owners of the shares held by this entity. Read SEC document |
| May 30, 2018 Filed May 31, 2018 15:26 UTC |
QUAY STEVEN CDirector · President & CEO
|
PurchaseSeries B Convertible Preferred Stock · Derivative | 8 | $1,000.00 Strike: $3.52 | $8,000.00 |
DisclosureSEC source: 0001615774-18-004657 · s110546_form4.xml · derivative · entry 1 QUAY STEVEN C · CIK 0001008227 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 8 Underlying: Common Stock · 2,273 shares Expires not disclosed F1 · derivative.exercise_price: Each share of Series B Convertible Preferred Stock is convertible into the number of shares of Common Stock equal to the stated value of $1,000 divided by $3.52. F4 · price: Shares of Series B Convertible Preferred Stock and Warrants were issued as part of a unit, with each unit consisting of one share of Series B Convertible Preferred Stock and 284 Warrants. F2 · derivative.expiration_date: Shares of Series B Convertible Preferred Stock do not expire. F3 · derivative.underlying_shares: No fractional shares will be issued upon conversion. At its election, the Company will either issue a cash adjustment or round up to the next whole share. The number reflected here assumes rounding up to the next whole share. F5 · ownership.nature: Securities are owned by Ensisheim Partners, LLC ("Ensisheim"). Shu-Chih Chen, Ph.D. and Steven C. Quay, M.D., Ph.D., share voting and investment power over the securities held by Ensisheim. Ensisheim is solely owned and controlled by Drs. Chen and Quay, and, as a result, Drs. Chen and Quay are deemed to be beneficial owners of the shares held by this entity. Read SEC document |
| May 30, 2018 Filed May 31, 2018 19:29 UTC |
Chen Shu-ChihDirector
|
PurchaseWarrants · Derivative | 2,272 | $1,000.00 Strike: $4.05 | $2,272,000.00 |
DisclosureSEC source: 0001615774-18-004659 · s110547_form4.xml · derivative · entry 2 Chen Shu-Chih · CIK 0001552127 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 2,272 Underlying: Common Stock · 2,272 shares Expires 2022-05-30 F4 · price: Shares of Series B Convertible Preferred Stock and Warrants were issued as part of a unit, with each unit consisting of one share of Series B Convertible Preferred Stock and 284 Warrants. F5 · ownership.nature: Securities are owned by Ensisheim Partners, LLC ("Ensisheim"). Shu-Chih Chen, Ph.D. and Steven C. Quay, M.D., Ph.D., share voting and investment power over the securities held by Ensisheim. Ensisheim is solely owned and controlled by Drs. Chen and Quay, and, as a result, Drs. Chen and Quay are deemed to be beneficial owners of the shares held by this entity. Read SEC document |
| May 30, 2018 Filed May 31, 2018 19:29 UTC |
Chen Shu-ChihDirector
|
PurchaseSeries B Convertible Preferred Stock · Derivative | 8 | $1,000.00 Strike: $3.52 | $8,000.00 |
DisclosureSEC source: 0001615774-18-004659 · s110547_form4.xml · derivative · entry 1 Chen Shu-Chih · CIK 0001552127 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 8 Underlying: Common Stock · 2,273 shares Expires not disclosed F1 · derivative.exercise_price: Each share of Series B Convertible Preferred Stock is convertible into the number of shares of Common Stock equal to the stated value of $1,000 divided by $3.52. F4 · price: Shares of Series B Convertible Preferred Stock and Warrants were issued as part of a unit, with each unit consisting of one share of Series B Convertible Preferred Stock and 284 Warrants. F2 · derivative.expiration_date: Shares of Series B Convertible Preferred Stock do not expire. F3 · derivative.underlying_shares: No fractional shares will be issued upon conversion. At its election, the Company will either issue a cash adjustment or round up to the next whole share. The number reflected here assumes rounding up to the next whole share. F5 · ownership.nature: Securities are owned by Ensisheim Partners, LLC ("Ensisheim"). Shu-Chih Chen, Ph.D. and Steven C. Quay, M.D., Ph.D., share voting and investment power over the securities held by Ensisheim. Ensisheim is solely owned and controlled by Drs. Chen and Quay, and, as a result, Drs. Chen and Quay are deemed to be beneficial owners of the shares held by this entity. Read SEC document |
| May 30, 2018 Filed May 31, 2018 19:24 UTC |
Guse KyleCFO, Gen Counsel and Secretary
|
PurchaseWarrants · Derivative | 2,272 | $1,000.00 Strike: $4.05 | $2,272,000.00 |
DisclosureSEC source: 0001615774-18-004655 · s110545_form4.xml · derivative · entry 2 Guse Kyle · CIK 0001566618 · CFO, Gen Counsel and Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,272 Underlying: Common Stock · 2,272 shares Expires 2022-05-30 F4 · price: Shares of Series B Convertible Preferred Stock and Warrants were issued as part of a unit, with each unit consisting of one share of Series B Convertible Preferred Stock and 284 Warrants. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.